Browse the latest research in
BMC Endocrine Disorders
BMC Endocrine Disorders
EVANGELISTA KENAN MALINDISA, Emmanuel Balandya, Marina Alois Njelekela, Fredirick MashiriMagnitude of Type 2 Diabetes Mellitus, Dyslipidemia and Hypertension Among Young Adults in Urban Settings: A Cross Sectional Survey in Mwanza, Tanzania
In Review
at
Posted Aug 20, 2019
BMC Endocrine Disorders
Xiaoyu Long, Xiaohui Zhu, Rong Li, Yan Yang, Jie QiaoC/EBP-β and SIRT1 regulate IL-18 expression in the proliferative phase endometrium of patients with polycystic ovary syndrome (PCOS)
In Review
atPosted Aug 20, 2019
BMC Endocrine Disorders
Ebrahim Falahati, Alireza Abdi, Hossein Ashterian, Nader Salari, Farzad MomenfarThe effect of educational intervention based on health belief on improvement of metabolic indices of patients with diabetes type II living in rural areas
In Review
atPosted Aug 19, 2019
BMC Endocrine Disorders
Forough Saki, azita salehifar, Seyed Reza Kassaee, Gholamhossein Ranjbar omraniAssociation of vitamin D and FGF23 with serum Ferritin in hypoparathyroid thalassemia, a case control study
In Review
atPosted Aug 17, 2019
BMC Endocrine Disorders
Ghodratollah Soltani, Arash Poursheikhani, Maryam Yassi, Abdorasool Hayatbakhsh, Matin Kerachian, Mohammad Amin KerachianObesity, Diabetes and the Risk of Colorectal Adenoma and Cancer
In Review
atPosted Aug 13, 2019
BMC Endocrine Disorders
Ginenus Fekadu, Kejela Bula, Getu BayisaChallenges and factors associated with poor glycemic control among type 2 diabetes mellitus patients at Nekemte referral hospital, western Ethiopia: cross-sectional study
In Review
atPosted Aug 13, 2019
BMC Endocrine Disorders
Christopher W Rowe, Sam Faulkner, Jonathan W Paul, Jorge M Tolosa, Craig Gedye, Cino Bendinelli, Katie Wynne, Shaun McGrath, John Attia, Roger Smith, Hubert HondermarckThe precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis
In Review
atUpdated Aug 13, 2019
BMC Endocrine Disorders
Koki Chiba, Mayuko Oita, Hiroyuki Nakamura, Ayano Utsunomiya, Yui Kosumi, Hiroshi Iesaka, Toshiyuki Watanabe, Tetsuya HoritaEfficacy of switching from dipeptidyl peptidase-4 inhibitors to dulaglutide in patients with type 2 diabetes
In Review
atPosted Aug 11, 2019
BMC Endocrine Disorders
Yasutaka Takada, Yukihiro Fujita, Ryoichi Bessho, Mao Sato, Tomoe Abe, Tsuyoshi Yanagimachi, Hidemitsu Sakagami, Atsuko Abiko, Yumi Takiyama, Tsuguhito Ota, Masakazu HanedaIncrement of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes: a retrospective study from glucagon stimulation test.
In Review
atPosted Jul 31, 2019
BMC Endocrine Disorders
Cuifeng Wei, Li Meng, Yuting ZhangmiR-450a-5p eliminats MGO-induced insulin resistance via targeting CREB
In Review
atPosted Jul 30, 2019